Pharmacogenomics at the post-pandemic: If not now, then when?

Al-Mahayri, Zeina N

Al-Mahayri, Zeina N.

Al-Mahayri ZN; Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Front Pharmacol ; 13: 1013527, 2022.

Article in English | MEDLINE | ID: covidwho-2058893

Keywords

COVID-19; cost-effective; pharmacogenomics (PGx); precision medicine; understudied groups

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549401
https://dx.doi.org/10.3389/fphar.2022.1013527

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Pharmacol Year: 2022 Document Type: Article Affiliation country: Fphar.2022.1013527

Similar

MEDLINE

LILACS

LIS

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549401
https://dx.doi.org/10.3389/fphar.2022.1013527

XML

PubMed Links

Search on Google